Medigen, Inc. is a biomedical and vaccine company developing vaccines for emerging infectious diseases, chronic diseases including cancer, and other biopharmaceutical applications. Its explicitly described capabilities include vaccine manufacturing, cGMP production of cell and virus banks, virus and protein drug substance production, fill-finish, VLP design and production, molecular biology, electron microscopy, protein expression, and protein purification.
FDA-compliant cGMP manufacturing
compliance_program
ICH-compliant cGMP manufacturing
compliance_program
Advanced BioScience Laboratories (ABL), IncFrom its Rockville base, Advanced BioScience Laboratories (ABL) develops and manufactures viral products for vaccines, gene therapies, oncolytic therapies and immunotherapies as a contract development and manufacturing organization. ABL brings more than 60 years of experience working with industry, government and academic partners, including over 30 years focused on viral-vector development and GMP production. Its Rockville facility is ISO 9001 accredited for viral drug-substance and aseptically prepared drug-product manufacturing, and the company has translated more than 100 processes from the laboratory bench into GMP suites.POTOMAC, MD
IDT BiologikaFounded in 1921, IDT Biologika is a Dessau-Rosslau-based global CDMO that develops and manufactures vaccines, viral vectors, biologics and sterile injectables from early development through commercial supply. Its particular strength is more than a century of experience working with live viruses, supported by BSL-2 facilities, integrated process development and manufacturing, and in-house quality and analytical services. Now part of SK bioscience, the company employs about 1,600 people and serves pharmaceutical and biotechnology customers as well as governments worldwide.ROCKVILLE, MD
TechnoVax IncFounded in 2004, privately held TechnoVax is a New York metro-area biotechnology company developing viral vaccines through a cell-based virus-like particle platform. Its near-clinical-stage work centers on vaccine candidates for influenza and RSV, including an inhaled powder approach developed with a pulmonary drug-delivery partner. The company also provides biological products and collaborative research services for vaccine, diagnostic, and research applications.ELMSFORD, NY
Emergent BioSolutionsFounded in 1998 to supply the U.S. government with anthrax vaccine, Emergent BioSolutions develops and manufactures medical countermeasures and other protective products for biological threats and opioid overdose emergencies. The company also operates as a strategic manufacturing partner, using specialized containment capabilities across four North American facilities to help biopharma companies, governments and nonprofits develop and make complex biological products. Its commercial portfolio includes NARCAN® Nasal Spray alongside preparedness products for threats such as anthrax, smallpox and botulism.ROCKVILLE, MD